Document is current
Any future updates will be listed below
-
Authors
Leskelä, Stina
Hoffmann, Dorit
Rostalski, Hannah
Huber, Nadine
Wittrahm, Rebekka
Hartikainen, Päivi
Korhonen, Ville
Leinonen, Ville
Hiltunen, Mikko
Solje, Eino
Remes, Anne M.
Haapasalo, Annakaisa http://orcid.org/0000-0003-0959-2957
-
Funding
Funding for this research was provided by:
Academy of Finland (315459, 315460, 307866)
Yrjö Jahnssonin Säätiö
Päivikki ja Sakari Sohlbergin Säätiö
Sigrid Juséliuksen Säätiö
Orionin Tutkimussäätiö
H2020 Marie Skłodowska-Curie Actions (740264, 740264)
Instrumentariumin Tiedesäätiö
Suomen Aivosäätiö
Emil Aaltosen Säätiö
ALS-tutkimuksen tuki ry
Strategic Neuroscience Funding of the University of Eastern Finland
- License Information
-
More Information
Article History
Received: 24 February 2021
Accepted: 25 June 2021
First Online: 30 July 2021
Declarations
:
: The authors declare no competing interests.
: All the participants gave written informed consent. The research in human subjects was performed in accordance with the ethical standards of Declaration of Helsinki and approved by the Research Ethics Committee of the Northern Savo Hospital District, Kuopio, Finland (ethical permits 16/2013 and 254/2015). Studies on FTLD patient–derived skin fibroblasts were performed with the permission 123/2016 from the Research Ethics Committee of the Northern Savo Hospital District.
: Not applicable.
